Loading...
Erlotinib eradicates brain metastases from epidermal growth factor receptor mutant non-small cell lung cancer
Erlotinib is active in patients with lung cancer; especially those who demonstrate a mutation in exons 18-21 in the epidermal growth factor receptor (EGFR) gene. Patients with lung cancer and brain metastases have poor prognosis as systemic chemotherapy is ineffective in treating the central nervous...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Medknow Publications & Media Pvt Ltd
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3507060/ https://ncbi.nlm.nih.gov/pubmed/23210009 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2231-0770.90916 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|